Testing effectiveness (Phase 2)Not Yet RecruitingNCT07266519
What this trial is testing
SIRIUS - Initial Combination Therapy With an Endothelin Receptor Antagonist, a Phosphodiesterase-5 Inhibitor and Sotatercept in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Philipps University Marburg 25